Literature DB >> 34588128

Regulating voluntary assisted dying practice: A policy analysis from Victoria, Australia.

Eliana Close1, Lindy Willmott2, Ben P White2.   

Abstract

BACKGROUND: Victoria is the first state in Australia to legalise voluntary assisted dying (elsewhere known as physician-assisted suicide and euthanasia). The Victorian law took effect in 2019 after an 18-month implementation period designed to facilitate policy development and other regulatory infrastructure.
OBJECTIVE: To study publicly available policy documents regarding voluntary assisted dying in Victoria and the issues they seek to regulate.
METHODS: Policies were identified using a combination of search strategies to capture documents aimed at a broad range of stakeholders including health practitioners, patients, and families. The policies were thematically analysed using the Framework Method.
RESULTS: The study identified 60 policies and five themes: 1) conceptions of policy purpose; 2) degree of support for VAD; 3) guidance about process; 4) navigating conscientious objection; and 5) conceptualising voluntary assisted dying and its relationship with other aspects of end-of-life care. Outside of the detailed Victorian Government policies, there was little practical guidance for voluntary assisted dying provision. Instead, the non-governmental policies tended to focus on positioning regarding VAD and entry into the process.
CONCLUSION: The study demonstrates the value of a planned implementation period for jurisdictions contemplating voluntary assisted dying reform and highlights the challenges in policymaking for a practice that is contentious for some.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34588128     DOI: 10.1016/j.healthpol.2021.09.003

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  1 in total

1.  Voluntary assisted dying: peak bodies must provide practical guidance.

Authors:  Eliana Close; Lindy Willmott; Ben P White
Journal:  Intern Med J       Date:  2022-06       Impact factor: 2.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.